Diane E. Sullivan - 18 Apr 2026 Form 4 Insider Report for AMARIN CORP PLC\UK (AMRN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Apr 2026, 17:00:04 UTC
Prior SEC filing
03 Jun 2025
Next SEC filing
04 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Provoost, by power of attorney

Key filing fact

Diane E. Sullivan filed Form 4 for AMARIN CORP PLC\UK (AMRN) on 21 Apr 2026.

Key facts

  • This page summarizes Diane E. Sullivan's Form 4 filing for AMARIN CORP PLC\UK (AMRN).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 21 Apr 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 03 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001968736 Primary reporting owner

Sullivan Diane E.

Relationship
Director
Address
C/O AMARIN PHARMA, INC., 440 US HIGHWAY 22, BRIDGEWATER
Signature
/s/ Jonathan Provoost, by power of attorney
Signature date
21 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMRN transaction

American Depositary Shares

Options Exercise

Transaction value
Shares
+838
Change %
+209%
Price
Shares after
1,239
Date
18 Apr 2026
Ownership
Direct
Footnotes
F1, F2, F3
AMRN transaction

American Depositary Shares

Tax liability

Transaction value
Shares
-403
Change %
-33%
Price
$14.98*
Shares after
836
Date
18 Apr 2026
Ownership
Direct
Footnotes
F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMRN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
+838
Change %
Price
$0.000000*
Shares after
838
Date
18 Apr 2026
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
838
Exercise price
$0.000000
Footnotes
F1, F2, F3, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change.

Footnote F2

On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted 2,514 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027.

Footnote F3

Not applicable.

Footnote F4

Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.

Footnote F5

Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .